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SALMON CALCITONIN STIMULATES CARTILAGE
FORMATION BY INDUCTION OF COLLAGEN TYPE II AND
PROTEOGLYCAN SYNTHESIS IN ARTICULAR
CARTILAGE
B-C. Sondergaard, E.U. Sumer, C. Christiansen, M.A. Karsdal
Nordic Bioscience, Herlev, Denmark
Purpose: Much attention has been devoted to understanding the
catabolic degradation of cartilage involving enzyme activity. Much
less is currently understood with regards to cartilage formation or
even regeneration. Calcitonin has been shown to have beneﬁcial
effect on cartilage degradation in in vitro and in vivo pre-clinical
studies. Additionally, reports show that calcitonin has anabolic
effects on isolated chondrocytes. We investigated the anabolic
potential of salmon calcitonin and insulin-like growth factor (IGF)
in combination in an in vitro model of cartilage formation. We
used an articular cartilage explants model, that has the extra-
cellular matrix intact and preserves the chondrocyte phenotype
compared isolated chondrocytes, and thereby may represent a
more in vivo like system.
Methods: Articular cartilage explants was harvested from bovine
stiﬂe joints and cultured with doses of salmon calcitonin [0, 1, 10
nM] in DMEM:F12. To investigate the effects of calcitonin in com-
bination with IGF other explants were co-cultured with salmon
calcitonin [0, 1, 10 nM] plus [0.1 ng/mL] IGF. The medium was
refreshed 3 times a week and the release of protein fragments
were evaluated in the conditioned medium. As negative control
other cartilage explants were metabolic inactivated by freeze and
thaw cycles and 100 ng/mL IGF was used as positive control.
Alamarblue was used to investigate the metabolic activity after
the 3 weeks of culture. Collagen type II formation was quanti-
ﬁed by PIINP ELISA measuring pro-peptides of collagen type II.
Total core-protein-aggrecan turnover was measured by a G1-G2
ELISA. Sulphated and glycosylated aggrecan turnover and re-
tention in the cartilage was measured in the alcian blue binding
assay. To assess the retained proteins after 3-weeks of culture,
the explants were pulverized in N2 and the proteins solubilised
with protease inhibitors. The total amount of proteoglycans was
measured in the cartilage explants extracts.
Results: After 3 weeks of culture, the explants cultured as
control had a lower amount of retained proteoglycans compared
to the metabolic inactive explants without chondrocyte mediated
metabolism, 53%, P<0.001. The positive control 100 ng/mL IGF
increased the proteoglycan levels by 175%, P<0.05 compared to
control. Treatment with salmon calcitonin signiﬁcantly increased
the content of proteoglycans in extracted cartilage explants, 1 nM
by 100%, P <0.05 and 10 nM by 60%, P <0.001, compared to
control. This was reﬂected by the quantiﬁcation of released G1-
G2. On the last day of culture, explants treated with 10 nM and
1 nM salmon calcitonin had 100% and 40% higher G1-G2 level
compared to control, albeit only borderline statically signiﬁcant.
With regard to collagen type II, salmon calcitonin stimulated the
collagen type II formation signiﬁcantly in both doses compared
to control, 1 nM by 167% and 10 nM by 129%, P<0.05. IGF 100
ng/mL, increased formation of collagen type II by 125%, P<0.05
compared to control. We further investigated possible synergistic
effects of calcitonin and IGF. Simulation of articular cartilage with
IGF and calcitonin, resulted in 200% increased collagen type II
synthesis compared to either alone at 1 nM but not at 10 nM
calcitonin, suggesting biphasic effects.
Conclusions: We show that stimulation with salmon calcitonin
signiﬁcantly increased the levels of extracellular matrix proteins
in the cartilage. When chondrocytes were exposed to both IGF
and calcitonin the anabolic response was considerably enlarged.
This suggests an overlap between the anabolic pathways of IGF
and calcitonin. These data begin to elucidate possible anabolic
effects of calcitonin on articular cartilage.
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ACTIVATION OF MAP KINASES IN NORMAL AND
OSTEOARTHRITIC HUMAN ARTICULAR
CHONDROCYTES IN REPONSE TO MECHANICAL
STIMULATION
Y. Zhou, S.J. Millward-Sadler, C. Beadle, D.M. Salter, G. Nuki
University of Edinburgh, Edinburgh, United Kingdom
Purpose: Articular cartilage matrix synthesis and integrity are
critically dependent on mechanical stimulation (MS). Human
articular chondrocytes (HAC) from normal, but not from os-
teoarthritic (OA) cartilage, respond to cyclical MS with an in-
crease in aggrecan mRNA and a decrease in MMP-3 mRNA1
[1]. The mitogen activated protein kinases (MAPKs) are a family
of intracellular proteins that are involved in a broad range of
cellular responses that lead to activation of transcription factors
and gene expression in response to growth factors, cytokines
and a wide variety of environmental stresses. The aim of this
study was to examine the effect of MS on the phosphorylation of
MAPKs in normal and OA HAC under conditions known to alter
aggrecan and MMP-3 mRNA1.
Methods: Articular cartilage was obtained from patients under-
going knee joint replacement. Cartilage was graded macroscop-
ically for OA [2]. Afer enzymatic isolation Chondrocytes were
isolated and cultured in non-conﬂuent monolayer at a density of
5 x 104/ml in Iscove’s Medium with 10% FCS and 5% CO2. The
cells were mechanically stimulated for 1, 5, 10 and 20 minutes
at 0.33 Hz and 3700 µstrain in the absence or presence of
the p38 inhibitor SB203580 and the JNK inhibitor SP600125.
Proteins were extracted and analysed by Western blotting. The
membranes were probed with polyclonal rabbit phospho-speciﬁc
antibodies to p38 MAPK, extracellular-signal regulated kinases
(ERK1/2) and c-Jun N-terminal kinases (JNK), stripped and then
reprobed for total protein with phosphorylation-status indepen-
dent antibodies.
Results: p38 and ERK1/2 were identiﬁed in unstimulated human
articular chondrocytes in primary culture but JNK isoforms could
not be detected. Phosphorylation of p38 was increased in OA
chondrocytes following 5, 10 and 20 minutes MS but there was
no evidence of phosphorylation of p38 in normal chondrocytes
in response to MS. Increased phosphorylation of ERK1/2 was
detected in normal chondrocytes following 20 minutes MS but
ERK1/2 phosphorylation was increased in only 1/3 OA primary
cultures following 10 and 20 minutes MS. There was no evidence
of a phosphorylated 54 kDa JNK isoform after 1, 5, 10 or 20
minutes MS in OA chondrocytes, but the polyclonal phospho-
speciﬁc JNK antibody identiﬁed 44kDa and 42kDa proteins which
are likely to be ERK1/2. Phosphorylation of p38 induced by MS
was blocked by SB203580 at concentrations of 1µM to 10µM but
paradoxically increased at higher concentrations of the inhibitor
(20µM, 50µM). p38 phosphorylation was further increased in the
presence of 10µM SP600125. Phosphorylated ERK1/2 and the
the 44kDa and 42kDa protein bands detected with phospho-JNK
antibody following MS were blocked with the SP600125 JNK
inhibitor at concentrations >10µM.
Conclusions: Unstimulated normal and OA chondrocytes ex-
press p38 and ERK1/2 MAPKs in primary culture. The absence
of p38 phosphorylation in normal chondrocytes following MS
that leads to changes in aggrecan and MMP3 mRNA suggests
that p38 is not involved in the intra cellular signaling cascade
that leads to this anabolic response. The phosphorylation of p38
in OA chondrocytes following MS could be associated with al-
tered intracellular signal transduction that results in the failure
of OA chondrocytes to increase aggrecan, or decrease MMP-
3 mRNA following MS [1]. The phosphorylation of ERK1/2 in
normal chondrocytes following MS that leads to up-regulation of
